HB+ is proud to partner with the National Minority Health Association to help bring about health equity and close the disparity gap in health and healthcare for underserved, marginalized, hard-to-reach, and minority communities.

Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin-Madison researchers are evaluating after they discovered a key process that fuels the blood cancers’ resistance to current drugs.

Read More